Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;27(3):245-252.
doi: 10.1002/pds.4381. Epub 2018 Jan 11.

Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)

Xavier Kurz  1 , Susana Perez-Gutthann  2 ; ENCePP Steering Group
Affiliations

Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)

Xavier Kurz et al. Pharmacoepidemiol Drug Saf. 2018 Mar.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of 83 data sources registered in ENCePP (as of 31/07/2017), by type chosen by the center registering the study (the total is 138 as a same data source may be of several types)
Figure 2
Figure 2
Number of studies registered in the EU PAS Register by ENCePP centers and other centers, 2011 to 2017 (total: 1145)
Figure 3
Figure 3
Distribution of studies registered in the EU PAS Register as of 31/07/2017 and requested by a regulatory authority (n = 583), by regulatory status
Figure 4
Figure 4
Distribution of 1145 studies registered in the EU PAS Register as of 31/07/2017 according to the main scope(s) (the total is 1716 as more than 1 scope is mentioned for some studies)
Figure 5
Figure 5
Number of times the electronic ENCePP Guide on Methodological Standards in Pharmacoepidemiology was viewed and downloaded from July 2012 to July 2017 [Colour figure can be viewed at wileyonlinelibrary.com]
See this image and copyright information in PMC

References

    1. Blake KV, de Vries CS, Arlett P, Kurz X, Fitt H. Increasing scientific standards, independence and transparency in post‐authorisation studies: the role of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Pharmacoepidemiol Drug Saf. 2012;21(7):690‐696. - PubMed
    1. Laporte JR. Fifty years of pharmacovigilance—medicines safety and public health. Pharmacoepidemiol Drug Saf. 2016;25(6):725‐732. - PubMed
    1. Arlett P, Sarac SB, Thomson A, et al. The European Medicines Agency's use of prioritised independent research for best evidence in regulatory action on diclofenac. Pharmacoepidemiol Drug Saf. 2014;23(4):431‐434. - PubMed
    1. Blake KV, Prilla S, Accadebled S, et al. European Medicines Agency review of post‐authorisation studies with implications for the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Pharmacoepidemiol Drug Saf. 2011;20(10):1021‐1029. - PubMed
    1. Persson I, Fitt H, Jekerle V. Model for ENCePP. European Medicines Agency, May 2007. http://www.encepp.eu/publications/documents/ENCePPConceptPaper_May07.pdf [last accessed on 12/10/2017]

MeSH terms